Physician profile
Susan Hoki
NPI 1750540266
$1,556.30
in general payments reported to CMS, 2019-2025
12 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $110 · 2021: $171 · 2022: $32.78 · 2023: $317 · 2024: $382 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.76 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $716.54 | 2020-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Sun Pharmaceutical Industries INC. | $183.52 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $133.14 | 2019-2021 | |
| Biotissue Holdings INC. | $95.76 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $84.97 | 2023 | |
| Bausch & Lomb Americas INC. | $69.28 | 2022-2025 | Vyzulta, Miebo, Envista Envy Iol |
| Kala Pharmaceuticals, INC. | $60.99 | 2019 | |
| Thea Pharma INC. | $60.23 | 2023-2024 | Iyuzeh |
| Abbvie INC. | $58.62 | 2023-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $43.80 | 2024 | Tecnis Iol, Lipiflow System Activator (Disposable) |
| Dompe US, INC. | $31.29 | 2025 | Oxervate |
| Allergan, INC. | $18.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Hoki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.